glp-1 treatment for newly diagnosed diabetes guidelines Where GLP-1RAs fit into current T2DM guidelines. Reproduced with New nice guidelines for diabetes

What Recent Research and Regulatory Updates Show A 2024 Danish study found that adults with type 2 diabetes who used semaglutide once a week were more than twice as likely to develop NAION within five years compared with non-users (HR 2.19), with a median onset of 22 months after starting the medication

The current data has shown good safety profile and lowering of hepatosteatosis

Cuando se trata de controlar el peso, la capacidad natural del GLP-1 para reducir el apetito y favorecer la regulacin de la glucemia puede hacerlo muy eficaz

This probiotic and postbiotic formulation aims to maintain a healthy digestive system and support overall wellness

The medical director of the VCU Health Medical Weight Loss Program explains what these medications do to the body and why they might not be suited for everyone

This effect may lower blood pressure and reduce excessive sympathetic drive in HF